Cite

    Dangerfield, C., Sherrard-Smith, E., Green, N., Harding-Esch, E., Howell-Jones, R., Choi, Y., Lowndes, C., & White, P. (n.d.). p09.13 Impact and cost-effectiveness of point-of-care testing for chlamydia: accounting for geographic variation in infection burden and testing rates, health service configuration, and implementation strategy. Sexually transmitted infections, 91, A152–A153. http://access.bl.uk/ark:/81055/vdc_100135126578.0x000012